OVERLAPPING SUBSTRATE SPECIFICITIES AND TISSUE DISTRIBUTION OF CYTOCHROME-P450 3A AND P-GLYCOPROTEIN - IMPLICATIONS FOR DRUG-DELIVERY AND ACTIVITY IN CANCER-CHEMOTHERAPY

被引：744

作者：

WACHER, VJ ^{[1
]}

WU, CY ^{[1
]}

BENET, LZ ^{[1
]}

机构：

[1] UNIV CALIF SAN FRANCISCO, DEPT PHARM, SAN FRANCISCO, CA 94143 USA

来源：

MOLECULAR CARCINOGENESIS | 1995年 / 13卷 / 03期

关键词：

METABOLISM; COUNTERTRANSPORT; MULTIDRUG RESISTANCE;

D O I：

10.1002/mc.2940130302

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

收藏

页码：129 / 134

页数：6

相关论文

共 105 条

[71] INHIBITION OF HEPATIC-MICROSOMAL DRUG-METABOLISM BY THE CALCIUM-CHANNEL BLOCKERS DILTIAZEM AND VERAPAMIL
RENTON, KW
[J]. BIOCHEMICAL PHARMACOLOGY, 1985, 34 (14) : 2549 - 2553
[72] CLONING AND CHARACTERIZATION OF A NOVEL CYP3A1 ALLELIC VARIANT - ANALYSIS OF CYP3A1 AND CYP3A2 SEX-HORMONE-DEPENDENT EXPRESSION REVEALS THAT THE CYP3A2 GENE IS REGULATED BY TESTOSTERONE
RIBEIRO, V
LECHNER, MC
[J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1992, 293 (01) : 147 - 152
[73] AMPLIFICATION OF P-GLYCOPROTEIN GENES IN MULTIDRUG-RESISTANT MAMMALIAN-CELL LINES
RIORDAN, JR
DEUCHARS, K
KARTNER, N
ALON, N
TRENT, J
LING, V
[J]. NATURE, 1985, 316 (6031) : 817 - 819
[74] THE CLINICAL-PHARMACOLOGY AND USE OF ANTIMICROTUBULE AGENTS IN CANCER CHEMOTHERAPEUTICS
ROWINSKY, EK
DONEHOWER, RC
[J]. PHARMACOLOGY & THERAPEUTICS, 1991, 52 (01) : 35 - 84
[75] SAEKI T, 1993, J BIOL CHEM, V268, P6077
[76] P-GLYCOPROTEIN-MEDIATED TRANSCELLULAR TRANSPORT OF MDR-REVERSING AGENTS
SAEKI, T
UEDA, K
TANIGAWARA, Y
HORI, R
KOMANO, T
[J]. FEBS LETTERS, 1993, 324 (01) : 99 - 102
[77] CHROMOSOME CHANGES IN BLADDER-CANCER - CLINICAL AND OTHER CORRELATIONS
SANDBERG, AA
[J]. CANCER GENETICS AND CYTOGENETICS, 1986, 19 (1-2) : 163 - 175
[78] CHROMOSOMAL-ABNORMALITIES AND RELATED EVENTS IN PROSTATE-CANCER
SANDBERG, AA
[J]. HUMAN PATHOLOGY, 1992, 23 (04) : 368 - 380
[79] SATTLER M, 1992, DRUG METAB DISPOS, V20, P753
[80] SCHUETZ EG, 1984, J BIOL CHEM, V259, P2007

← 2 3 4 5 6 7 8 9 10 11 →